Abstract
SIRT6 is one of the seven members of the NAD-dependent family of sirtuins mammals. The pleotropic identity of SIRT6 is manifested into several catalytic activities such as deacetylation, deacylation and ribosylation, which allow the targeting of a variety of protein substrates, that influence the physiology of multiple cell types and tissues. SIRT6- dependent deacetylation of histone H3 at lysines 9 and 56 is required for the regulation of genes associated with glucose/ lipid metabolism as well as the maintenance of telomeric regions and the repair of DNA double strand breaks. Importantly, SIRT6 depletion alters the levels of acetylated histone H3 causing a deregulation of genes involved in glycolysis and the Myc-target network, which results in tumorigenesis. Hence, SIRT6 has been recently categorized as a tumor suppressor. The deacylation activity of SIRT6 has been attributed to the regulation of TNF-α secretion. However, the physiological relevance of this newly discovered catalytic activity of SIRT6 remains to be determined in vivo. SIRT6 also undergoes auto-ribosylation, which might contribute to a self-regulation of catalytic functions. SIRT6-mediated ribosylation also enhances PARP1-dependent DNA repair under oxidative stress and aging. Overall, SIRT6 is a critical enzyme required to maintain glucose/lipid homeostasis and genomic stability, thereby promoting resistance to oxidative stress and DNA damage, which are associated to age-related illness. Evocative of its ancestor, yeast Sir2, SIRT6 has the ability to increase lifespan in mice. SIRT6 deficiency is associated with various diseases including inflammation, cardiac hypertrophy, liver dysfunction, adipocyte/muscle disorders, and cancer. This review describes the most current information regarding the molecular and physiological relevance of SIRT6 in the context of epigenetics, metabolism and disease.
Keywords: Aging, cancer, deacetylase, epigenetics, glycolysis, metabolism, sirtuin, SIRT6.
Current Topics in Medicinal Chemistry
Title:The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease
Volume: 13 Issue: 23
Author(s): Jean-Pierre Etchegaray, Lei Zhong and Raul Mostoslavsky
Affiliation:
Keywords: Aging, cancer, deacetylase, epigenetics, glycolysis, metabolism, sirtuin, SIRT6.
Abstract: SIRT6 is one of the seven members of the NAD-dependent family of sirtuins mammals. The pleotropic identity of SIRT6 is manifested into several catalytic activities such as deacetylation, deacylation and ribosylation, which allow the targeting of a variety of protein substrates, that influence the physiology of multiple cell types and tissues. SIRT6- dependent deacetylation of histone H3 at lysines 9 and 56 is required for the regulation of genes associated with glucose/ lipid metabolism as well as the maintenance of telomeric regions and the repair of DNA double strand breaks. Importantly, SIRT6 depletion alters the levels of acetylated histone H3 causing a deregulation of genes involved in glycolysis and the Myc-target network, which results in tumorigenesis. Hence, SIRT6 has been recently categorized as a tumor suppressor. The deacylation activity of SIRT6 has been attributed to the regulation of TNF-α secretion. However, the physiological relevance of this newly discovered catalytic activity of SIRT6 remains to be determined in vivo. SIRT6 also undergoes auto-ribosylation, which might contribute to a self-regulation of catalytic functions. SIRT6-mediated ribosylation also enhances PARP1-dependent DNA repair under oxidative stress and aging. Overall, SIRT6 is a critical enzyme required to maintain glucose/lipid homeostasis and genomic stability, thereby promoting resistance to oxidative stress and DNA damage, which are associated to age-related illness. Evocative of its ancestor, yeast Sir2, SIRT6 has the ability to increase lifespan in mice. SIRT6 deficiency is associated with various diseases including inflammation, cardiac hypertrophy, liver dysfunction, adipocyte/muscle disorders, and cancer. This review describes the most current information regarding the molecular and physiological relevance of SIRT6 in the context of epigenetics, metabolism and disease.
Export Options
About this article
Cite this article as:
Etchegaray Jean-Pierre, Zhong Lei and Mostoslavsky Raul, The Histone Deacetylase SIRT6: At the Crossroads Between Epigenetics, Metabolism and Disease, Current Topics in Medicinal Chemistry 2013; 13 (23) . https://dx.doi.org/10.2174/15680266113136660213
DOI https://dx.doi.org/10.2174/15680266113136660213 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Translation of a Tissue-Selective Rexinoid, UAB30, to the Clinic for Breast Cancer Prevention
Current Topics in Medicinal Chemistry Cadherins: The Superfamily Critically Involved in Breast Cancer
Current Pharmaceutical Design Chemoprevention of Cancers in Gastrointestinal Tract with Cyclooxygenase 2 Inhibitors
Current Pharmaceutical Design Transcription Factor Profiling Shows New Ways Towards New Treatment Options of Cutaneous T cell lymphomas
Current Drug Discovery Technologies Cervical Cancer: Are There Potential New Targets? An Update on Preclinical and Clinical Results
Current Drug Targets Extracellular Citrate in Health and Disease
Current Molecular Medicine Analysis of Simple Sequence Repeats in Mammalian Cell Cycle Genes
Recent Advances in DNA & Gene Sequences (Discontinued) B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry Current Status and Perspectives Regarding the Therapeutic Potential of Targeting EGFR Pathway by Curcumin in Lung Cancer
Current Pharmaceutical Design Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Impact of Epigenetic Alterations in the Development of Oral Diseases
Current Medicinal Chemistry Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy
Current Cancer Drug Targets Interactome Analysis of the Differentially Expressed Proteins in Uterine Leiomyoma
Anti-Cancer Agents in Medicinal Chemistry Antiangiogenesis and Radiotherapy: What Is the Role of Combined Modality Treatment?
Current Medicinal Chemistry - Anti-Cancer Agents Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy Current Status of SUMOylation Inhibitors
Current Medicinal Chemistry Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Patent Selections
Recent Patents on Biomarkers A New Twist in Cellular Resistance to the Anticancer Drug Bleomycin-A5
Current Drug Metabolism Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design